CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE4914.7039.1 (+0.8 %)
PREV CLOSE () 4875.60
OPEN PRICE () 4871.35
BID PRICE (QTY) 4904.50 (1)
OFFER PRICE (QTY) 4914.70 (1)
VOLUME 755
TODAY'S LOW / HIGH ()4852.05 4930.75
52 WK LOW / HIGH ()4050.1 6452.85
NSE4907.6032.4 (+0.66 %)
PREV CLOSE() 4875.20
OPEN PRICE () 4887.40
BID PRICE (QTY) 4902.25 (1)
OFFER PRICE (QTY) 4907.60 (1)
VOLUME 3351
TODAY'S LOW / HIGH() 4846.60 4929.50
52 WK LOW / HIGH ()3950 6451.15
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1950

Management Info :

Pradip Shah - Chairman Meenakshi Nevatia - Managing Director

Registered Office :

Address : The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone : 022 6693 2000

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
11Dec Pfizer informs about issuance of dupli
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..
08Aug Pfizer informs about newspaper publica
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclos..
27May Pfizer informs about annual secretaria
In terms of Regulation 24(A) of the Securities and Exchange Board of Ind..
22Jan Pfizer informs about appointment of ex
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
18Aug Pfizer informs about change in managem
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit1583.55513.3
Gross Profit 2152.3 7460.7
Operating Profit 2323.28158.1
Net Sales 5885.921931.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29244.55 (2.13%)
M.Cap ( in Cr)
62258.22
Neuland Laboratories (BSE)
 13504.85 (0.44%)
M.Cap ( in Cr)
17281.92
Akums Drugs & Pharmaceuticals (BSE)
 662.50 (9.07%)
M.Cap ( in Cr)
10396.66
Ajanta Pharma (BSE)
 2845.25 (1.79%)
M.Cap ( in Cr)
35609.94
Alkem Laboratories (BSE)
 5450.00 (0.84%)
M.Cap ( in Cr)
65162.33
Shareholding Pattern
PROMOTERS 63.92%
NON-INSTITUTION 16.5%
MUTUAL FUNDS/UTI 10.43%
FI/BANKS/INSURANCE 5.53%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX78955.85483.37 (0.62%)
NIFTY23896.50146.30 (0.62%)
Dow Jones 43325.8028.77 (0.07%)
Nasdaq 20020.36-10.77 (-0.05%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI